Table 8.

HBB Pathogenic Variants Referenced in This GeneReview

Reference SequencesDNA Nucleotide Change
(Alias 1)
Predicted Protein Change 2
(Alias 1)
Comment [Reference]
NM_000518​.5 c.-151C>T
(-101C>T)
--Silent β+ variant (See Genotype-Phenotype Correlations.)
c.-142C>T
(-92C>T)
--
c.-140C>T
(-90C>T)
--Mild β+ variant (See Genotype-Phenotype Correlations.)
c.-138C>A
(-88C>A)
--
c.-138C>T
(-88C>T)
--
c.-137C>A
(-87C>A)
--Mild β+ variant (See Genotype-Phenotype Correlations.)
c.-137C>G
(-87C>G)
--
c.-137C>T
(-87C>T)
--
c.-136C>G
(-86C>G)
--
c.-136C>T
(-86C>T)
--Mild β+ variant (See Genotype-Phenotype Correlations.)
c.-81A>G
(-31A>G)
--
c.-80T>A
(-30T>A)
--
c.-79A>G
(-29A>G)
--
c.-78A>G
(-28A>G)
--
  • One of 4 common pathogenic variants in Chinese population 4
  • One of 6 common pathogenic variants in Taiwanese population 4
c.-50A>C
(+1A>C)
Silent β+ variant (See Genotype-Phenotype Correlations.)
c.-41del>T
(+10delT)
--Mild β+ variant (See Genotype-Phenotype Correlations.)
c.-29G>A
(+22G>A)
--
c.-18C>G
(+33C>G)
--
NM_000518​.5
NP_000509​.1
c.20delAp.Glu7GlyfsTer13
(Glu6GlyfsTer12)
Mild β0 variant (See Genotype-Phenotype Correlations.)
c.25_26delAAp.Lys9ValfsTer14
(Lys8ValfsTer13)
c.27dupGp.Ser10ValfsTer14
(Ser9ValfsTer13)
One of 6 common pathogenic variants in Middle Eastern population 4
c.52A>Tp.Lys18Ter
(Lys17Ter)
  • One of 4 common pathogenic variants in Chinese population 4
  • One of 6 common pathogenic variants in Taiwanese population 4
c.59A>Gp.Asn20Ser
(Asn19Ser)
NM_000518​.5 c.75T>A
(IVS1-18T>A)
See footnote 5.
NM_000518​.5
NP_000509​.1
c.82G>Tp.Ala28Ser
(Ala27Ser)
NM_000518​.5 c.93-21G>A
(IVS1-21G>A)
--One of 6 common pathogenic variants in Mediterranean population 4
c.92+1G>A
(IVS1+1G>A)
--
c.92+5G>C
(IVS1+5G>C)
--
  • One of 6 common pathogenic variants in African & African American populations 3
  • One of 6 common pathogenic variants in Middle Eastern & Taiwanese populations 4
c.92+6T>C
(IVS1+6T>C)
--
NM_000518​.5
NP_000509​.1
c.118C>Tp.Gln40Ter
(Gln39Ter)
One of 6 common pathogenic variants in Mediterranean & Middle Eastern populations 4
c.126_129delCTTTp.Phe42LeufsTer19
  • One of 4 common pathogenic variants in Chinese population 4
  • One of 6 common pathogenic variants in Taiwanese population 4
c.135delCp.Phe46LeufsTer16
(Phe45LeufsTer15)
One of 6 common pathogenic variants in Middle Eastern population 4
NM_000518​.5 c.316-197C>T
(IVS2+654C>T)
--
  • One of 4 common pathogenic variants in Chinese population 4
  • One of 6 common pathogenic variants in Taiwanese population 4
c.316-106C>G
(IVS2+745C>G)
--One of 6 common pathogenic variants in Mediterranean population 4
c.316-7C>G
(IVS2-7C>G)
Mild β+ variant (See Genotype-Phenotype Correlations.)
c.316-2A>G
(IVS2-2A>G)
--One of 6 common pathogenic variants in African & African American populations 3
c.316-2A>C
(IVS2-2A>C)
--
c.315+1G>A
(IVS2+1G>A)
--One of 6 common pathogenic variants in Middle Eastern population 4
c.*6C>G--Silent β+ variant (See Genotype-Phenotype Correlations.)
c.*110T>C--Mild β+ variant (See Genotype-Phenotype Correlations.)
c.*111A>G--
c.*113A>G--Silent β+ variant (See Genotype-Phenotype Correlations.)

Variants listed in the table have been provided by the author. GeneReviews staff have not independently verified the classification of variants.

GeneReviews follows the standard naming conventions of the Human Genome Variation Society (varnomen​.hgvs.org). See Quick Reference for an explanation of nomenclature.

1.

Variant designation that does not conform to current naming conventions

2.

Variant nomenclature following current guidelines has been provided. However, because the initiation methionine is not part of the mature beta globin protein, the long-standing convention of numbering the amino acids is to begin with the next amino acid (Val). For consistency with the literature and the Globin Gene Server (globin​.bx.psu.edu), the traditional amino acid numbering has been provided.

3.

HBB pathogenic variants included in Table 8 account for 75%-80% of pathogenic variants in this population.

4.

HBB pathogenic variants included in Table 8 account for 91%-95% of pathogenic variants in this population.

5.

Nucleotide substitution activates a splice site.

From: Beta-Thalassemia

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.